{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:43:17Z","timestamp":1789083797747,"version":"build-2803163510"},"reference-count":91,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,12,30]]},"abstract":"<jats:sec><jats:title\/><jats:p>A large plethora of drugs and promising lead compounds contain halogens in their structures. The introduction of such moieties strongly modulates their physical-chemical features as well as pharmacokinetic and pharmacodynamic profile. The most important outcome was shown to be the ability of these halogens to favourably influence the drug-target interaction and energetic stability within the active site by the establishment of halogen bonds. This review attempted to demonstrate the key role exerted by these versatile moieties when correctly located in an organic scaffold to display Monoamine Oxidase (MAO) inhibition and selectivity towards the B isoform of this important enzyme. Human MAOs are well-recognized as therapeutic targets for mood disorders and neurodegenerative diseases and medicinal chemists were prompted to discover the structural requirements crucial to discriminate the slight differences between the active sits of the two isoforms (MAO-A and MAOB). The analysis of the structure-activity relationships of the most important scaffolds (hydrazothiazoles, coumarins, chromones, chalcones, pyrazolines) and the impact of halogen (F, Cl, Br and I) insertion on this biological activity and isozyme selectivity have been reported being a source of inspiration for the medicinal chemists.<\/jats:p><\/jats:sec>","DOI":"10.2174\/0929867327666200121165931","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T12:01:33Z","timestamp":1579694493000},"page":"266-283","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["New Aspects of Monoamine Oxidase B Inhibitors: The Key Role of Halogens to Open the Golden Door"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6658-4497","authenticated-orcid":true,"given":"Bijo","family":"Mathew","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi-682 041, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8698-9440","authenticated-orcid":true,"given":"Simone","family":"Carradori","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, \u201cG. d\u2019Annunzio\u201d University of Chieti-Pescara, Chieti 66100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5701-6925","authenticated-orcid":true,"given":"Paolo","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0805-7840","authenticated-orcid":true,"given":"Md. Sahab","family":"Uddin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Southeast University, Dhaka, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-3712","authenticated-orcid":true,"given":"Hoon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, and Research Institute of Life Pharmaceutical Sciences, Sunchon National University, Suncheon 57922, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/13543776.2014.982535","volume":"25","author":"Carradori S.","year":"2015","unstructured":"Carradori S.; Petzer J.P.; Novel monoamine oxidase inhibitors: A patent review (2012 - 2014). Expert Opin Ther Pat 2015,25(1),91-110","journal-title":"Expert Opin Ther Pat"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2174\/1573408012666160402001715","volume":"12","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Mathew G.E.; Suresh J.; Ucar G.; Sasidharan R.; Vilapurathu J.K.; Anbazhagan S.; Jayaprakash V.; Monoamine oxidase inhibitors: Perspective design for the treatment of depression and, neurological disorders. Curr Enzym Inhib 2016,12,115-122","journal-title":"Curr Enzym Inhib"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"S287","DOI":"10.1038\/sj.bjp.0706464","volume":"147","author":"Youdim M.B.","year":"2006","unstructured":"Youdim M.B.; Bakhle Y.S.; Monoamine oxidase: isoforms and inhibitors in Parkinson\u2019s disease and depressive illness. Br J Pharmacol 2006,147(Suppl. 1),S287-S296","journal-title":"Br J Pharmacol"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/0929867305666220314202430","volume":"5","author":"Wouters J.","year":"1998","unstructured":"Wouters J.; Structural aspects of monoamine oxidase and its reversible inhibition. Curr Med Chem 1998,5(2),137-162","journal-title":"Curr Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1002\/med.2610150406","volume":"15","author":"Kalgutkar A.S.","year":"1995","unstructured":"Kalgutkar A.S.; Castagnoli N.; Testa B.; Selective inhibitors of monoamine oxidase (MAO-A and MAO-B) as probes of its catalytic site and mechanism. Med Res Rev 1995,15(4),325-388","journal-title":"Med Res Rev"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.2174\/1381612811319140004","volume":"19","author":"Ramsay R.R.","year":"2013","unstructured":"Ramsay R.R.; Inhibitor design for monoamine oxidases. Curr Pharm Des 2013,19(14),2529-2539","journal-title":"Curr Pharm Des"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"6717","DOI":"10.1021\/jm501690r","volume":"58","author":"Carradori S.","year":"2015","unstructured":"Carradori S.; Silvestri R.; New frontiers in selective human MAO-B Inhibitors. J Med Chem 2015,58(17),6717-6732","journal-title":"J Med Chem"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1021\/jm070677y","volume":"50","author":"Binda C.","year":"2007","unstructured":"Binda C.; Wang J.; Pisani L.; Caccia C.; Carotti A.; Salvati P.; Edmondson D.E.; Mattevi A.; Structures of human monoamine oxidase B complexes with selective noncovalent inhibitors: safinamide and coumarin analogs. J Med Chem 2007,50(23),5848-5852","journal-title":"J Med Chem"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1212\/WNL.67.7_suppl_2.S5","volume":"67","author":"Binda C.","year":"2006","unstructured":"Binda C.; Hub\u00e1lek F.; Li M.; Castagnoli N.; Edmondson D.E.; Mattevi A.; Structure of the human mitochondrial monoamine oxidase B: new chemical implications for neuroprotectant drug design. Neurology 2006,67(7)(Suppl. 2),S5-S7","journal-title":"Neurology"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"9750","DOI":"10.1073\/pnas.1633804100","volume":"100","author":"Binda C.","year":"2003","unstructured":"Binda C.; Li M.; Hubalek F.; Restelli N.; Edmondson D.E.; Mattevi A.; Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures. Proc Natl Acad Sci USA 2003,100(17),9750-9755","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1517\/13543776.2010.495716","volume":"20","author":"Bolasco A.","year":"2010","unstructured":"Bolasco A.; Carradori S.; Fioravanti R.; Focusing on new monoamine oxidase inhibitors. Expert Opin Ther Pat 2010,20(7),909-939","journal-title":"Expert Opin Ther Pat"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1002\/med.21561","volume":"39","author":"Tripathi R.K.P.","year":"2019","unstructured":"Tripathi R.K.P.; Ayyannan S.R.; Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. Med Res Rev 2019,39(5),1603-1706","journal-title":"Med Res Rev"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/17460441.2019.1637415","volume":"14","author":"Guglielmi P.","year":"2019","unstructured":"Guglielmi P.; Carradori S.; Ammazzalorso A.; Secci D.; Novel approaches to the discovery of selective human monoamine oxidase-B inhibitors: is there room for improvement? Expert Opin Drug Discov 2019,14(10),995-1035","journal-title":"Expert Opin Drug Discov"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acs.jpcb.6b09451","volume":"121","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; Adeniyi A.A.; Dev S.; Joy M.; Ucar G.; Mathew G.E.; Singh-Pillay A.; Soliman M.E.; Pharmacophore based 3D-QSAR analysis of thienyl chalcone as new class of human MAO-B inhibitors. Investigation of combined quantum chemical and molecular dynamics approach. J Phys Chem B 2017,121(6),1186-1203","journal-title":"J Phys Chem B"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"11645","DOI":"10.1002\/slct.201701213","volume":"2","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; Dev S.; Mathew G.E.; Marathakam A.; Krishnan G.K.; Refining the structural features of chromones as selective MAO-B inhibitors: exploration of combined pharmacophore-based 3D-QSAR and quantum chemical studies. ChemistrySelect 2017,2,11645-11652","journal-title":"ChemistrySelect"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"42660","DOI":"10.1039\/C6RA00302H","volume":"6","author":"Kumar B.","year":"2016","unstructured":"Kumar B.; Sheetal S.; Mantha A.K.; Kumar V.; Recent developments on the structure\u2010activity relationship studies of MAO inhibitors and their role in different neurological disorders. RSC Advances 2016,6,42660-42683","journal-title":"RSC Advances"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1389450117666151209123402","volume":"18","author":"Kumar B.","year":"2017","unstructured":"Kumar B.; Gupta V.P.; Kumar V.; A perspective on monoamine oxidase enzyme as drug target. Challenges and opportunities. Curr Drug Targets 2017,18(1),87-97","journal-title":"Curr Drug Targets"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5114","DOI":"10.2174\/092986711797636090","volume":"18","author":"Secci D.","year":"2011","unstructured":"Secci D.; Bolasco A.; Chimenti P.; Carradori S.; The state of the art of pyrazole derivatives as monoamine oxidase inhibitors and antidepressant\/anticonvulsant agents. Curr Med Chem 2011,18(33),5114-5144","journal-title":"Curr Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2174\/1871524914666140129122632","volume":"13","author":"Mathew B.","year":"2013","unstructured":"Mathew B.; Suresh J.; Anbazhagan S.; Mathew G.E.; Pyrazoline: a promising scaffold for the inhibition of monoamine oxidase. Cent Nerv Syst Agents Med Chem 2013,13(3),195-206","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.2174\/156802612805220002","volume":"12","author":"Matos M.J.","year":"2012","unstructured":"Matos M.J.; Vi\u00f1a D.; Vazquez-Rodriguez S.; Uriarte E.; Santana L.; Focusing on new monoamine oxidase inhibitors: differently substituted coumarins as an interesting scaffold. Curr Top Med Chem 2012,12(20),2210-2239","journal-title":"Curr Top Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1080\/14756366.2019.1653864","volume":"34","author":"Guglielmi P.","year":"2019","unstructured":"Guglielmi P.; Secci D.; Petzer A.; Bagetta D.; Chimenti P.; Rotondi G.; Ferrante C.; Recinella L.; Leone S.; Alcaro S.; Zengin G.; Petzer J.P.; Ortuso F.; Carradori S.; Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity. J Enzyme Inhib Med Chem 2019,34(1),1511-1525","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1021\/jm801496u","volume":"52","author":"Chimenti F.","year":"2009","unstructured":"Chimenti F.; Secci D.; Bolasco A.; Chimenti P.; Bizzarri B.; Granese A.; Carradori S.; Y\u00e1\u00f1ez M.; Orallo F.; Ortuso F.; Alcaro S.; Synthesis, molecular modeling, and selective inhibitory activity against human monoamine oxidases of 3-carboxamido-7-substituted coumarins. J Med Chem 2009,52(7),1935-1942","journal-title":"J Med Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00702-018-1881-5","volume":"125","author":"Tipton K.F.","year":"2018","unstructured":"Tipton K.F.; 90 years of monoamine oxidase: some progress and some confusion. J Neural Transm (Vienna) 2018,125(11),1519-1551","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cdc.2018.10.009","volume":"17-18","author":"Joy M.","year":"2018","unstructured":"Joy M.; Mathew B.; Sudarsanakumar C.; Structural features of safinamide: a combined hirshfeld surface analysis quantum chemical treatment. Chem Data Collect 2018,17-18,404-414","journal-title":"Chem Data Collect"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"12615","DOI":"10.1021\/jp906352e","volume":"113","author":"Lu Y.","year":"2009","unstructured":"Lu Y.; Wang Y.; Xu Z.; Yan X.; Luo X.; Jiang H.; Zhu W.C-X.; H contacts in biomolecular systems: how they contribute to protein-ligand binding affinity. J Phys Chem B 2009,113(37),12615-12621","journal-title":"J Phys Chem B"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1021\/jm3012068","volume":"56","author":"Wilcken R.","year":"2013","unstructured":"Wilcken R.; Zimmermann M.O.; Lange A.; Joerger A.C.; Boeckler F.M.; Principles and applications of halogen bonding in medicinal chemistry and chemical biology. J Med Chem 2013,56(4),1363-1388","journal-title":"J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1517\/17460441.2012.678829","volume":"7","author":"Lu Y.","year":"2012","unstructured":"Lu Y.; Liu Y.; Xu Z.; Li H.; Liu H.; Zhu W.; Halogen bonding for rational drug design and new drug discovery. Expert Opin Drug Discov 2012,7(5),375-383","journal-title":"Expert Opin Drug Discov"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00894-006-0130-2","volume":"13","author":"Clark T.","year":"2007","unstructured":"Clark T.; Hennemann M.; Murray J.S.; Politzer P.; Halogen bonding: the sigma-hole. Proceedings of \u201cModeling interactions in biomolecules II\u201d, Prague, September 5th-9th, 2005. J Mol Model 2007,13(2),291-296","journal-title":"J Mol Model"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00894-006-0154-7","volume":"13","author":"Politzer P.","year":"2007","unstructured":"Politzer P.; Lane P.; Concha M.C.; Ma Y.; Murray J.S.; An overview of halogen bonding. J Mol Model 2007,13(2),305-311","journal-title":"J Mol Model"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1039\/C2CC37584B","volume":"49","author":"Kol\u00e1\u0159 M.","year":"2013","unstructured":"Kol\u00e1\u0159 M.; Hobza P.; Bronowska A.K.; Plugging the explicit \u03c3-holes in molecular docking. Chem Commun (Camb) 2013,49(10),981-983","journal-title":"Chem Commun (Camb)"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1021\/acs.chemrev.5b00484","volume":"116","author":"Cavallo G.","year":"2016","unstructured":"Cavallo G.; Metrangolo P.; Milani R.; Pilati T.; Priimagi A.; Resnati G.; Terraneo G.; The halogen bond. Chem Rev 2016,116(4),2478-2601","journal-title":"Chem Rev"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/128_2014_573","volume":"358","author":"Cavallo G.","year":"2015","unstructured":"Cavallo G.; Metrangolo P.; Pilati T.; Resnati G.; Terraneo G.; Halogen bond: a long overlooked interaction. Top Curr Chem 2015,358,1-17","journal-title":"Top Curr Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ejmech.2019.03.063","volume":"173","author":"Fang W.Y.","year":"2019","unstructured":"Fang W.Y.; Ravindar L.; Rakesh K.P.; Manukumar H.M.; Shantharam C.S.; Alharbi N.S.; Qin H.L.; Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review. Eur J Med Chem 2019,173,117-153","journal-title":"Eur J Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.molstruc.2017.05.100","volume":"1146","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; Adeniyi A.A.; Joy M.; Mathew G.E.; Singh-Pillay A.; Sudarsanakumar C.; Soliman M.E.S.; Suresh J.; Anti-oxidant behaviour of functionalized chalcone-a combined quantum chemical and crystallographic structural investigation. J Mol Struct 2017,1146,301-308","journal-title":"J Mol Struct"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.bionut.2014.04.003","volume":"4","author":"Mathew B.","year":"2014","unstructured":"Mathew B.; Suresh J.; Anbazhagan S.; Paulraj J.; Krishnan G.K.; Heteroaryl chalcones: mini review about their therapeutic voyage. Bio Med Prev Nut 2014,4,451-458","journal-title":"Bio Med Prev Nut"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/s-2006-962604","volume":"53","author":"Tanaka S.","year":"1987","unstructured":"Tanaka S.; Kuwai Y.; Tabata M.; Isolation of monoamine oxidase inhibitors from Glycyrrhiza uralensis roots and the structure-activity relationship. Planta Med 1987,53(1),5-8","journal-title":"Planta Med"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/jm801590u","volume":"52","author":"Chimenti F.","year":"2009","unstructured":"Chimenti F.; Fioravanti R.; Bolasco A.; Chimenti P.; Secci D.; Rossi F.; Y\u00e1\u00f1ez M.; Orallo F.; Ortuso F.; Alcaro S.; Chalcones: a valid scaffold for monoamine oxidases inhibitors. J Med Chem 2009,52(9),2818-2824","journal-title":"J Med Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1016\/j.bmcl.2013.06.050","volume":"23","author":"Robinson S.J.","year":"2013","unstructured":"Robinson S.J.; Petzer J.P.; Petzer A.; Bergh J.J.; Lourens A.C.U.; Selected furanochalcones as inhibitors of monoamine oxidase. Bioorg Med Chem Lett 2013,23(17),4985-4989","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"7890","DOI":"10.1016\/j.bmc.2013.10.004","volume":"21","author":"Jo G.","year":"2013","unstructured":"Jo G.; Ahn S.; Kim B.G.; Park H.R.; Kim Y.H.; Choo H.A.; Koh D.; Chong Y.; Ahn J.H.; Lim Y.; Chromenylchalcones with inhibitory effects on monoamine oxidase B. Bioorg Med Chem 2013,21(24),7890-7897","journal-title":"Bioorg Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/cbdd.12458","volume":"85","author":"Morales-Camilo N.","year":"2015","unstructured":"Morales-Camilo N.; Salas C.O.; Sanhueza C.; Espinosa-Bustos C.; Sep\u00falveda-Boza S.; Reyes-Parada M.; Gonzalez-Nilo F.; Caroli-Rezende M.; Fierro A.; Synthesis, biological evaluation, and molecular simulation of chalcones and aurones as selective MAO-B inhibitors. Chem Biol Drug Des 2015,85(6),685-695","journal-title":"Chem Biol Drug Des"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"6486","DOI":"10.1016\/j.bmc.2015.08.012","volume":"23","author":"Choi J.W.","year":"2015","unstructured":"Choi J.W.; Jang B.K.; Cho N.C.; Park J.H.; Yeon S.K.; Ju E.J.; Lee Y.S.; Han G.; Pae A.N.; Kim D.J.; Park K.D.; Synthesis of a series of unsaturated ketone derivatives as selective and reversible monoamine oxidase inhibitors. Bioorg Med Chem 2015,23(19),6486-6496","journal-title":"Bioorg Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1871524915666151002124443","volume":"16","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Haridas A.; Suresh J.; Mathew G.E.; U\u00e7ar G.; Jayaprakash V.; Monoamine oxidase inhibitory actions of chalcones. A mini review. Cent Nerv Syst Agents Med Chem 2016,16(2),120-136","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.2174\/1871524919666190131160122","volume":"19","author":"Mathew B.","year":"2019","unstructured":"Mathew B.; Unraveling the structural requirements of chalcone chemistry towards monoamine oxidase inhibition. Cent Nerv Syst Agents Med Chem 2019,19(1),6-7","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bioorg.2015.07.001","volume":"62","author":"Mathew B.","year":"2015","unstructured":"Mathew B.; Mathew G.E.; U\u00e7ar G.; Baysal I.; Suresh J.; Vilapurathu J.K.; Prakasan A.; Suresh J.K.; Thomas A.; Development of fluorinated methoxylated chalcones as selective monoamine oxidase-B inhibitors: Synthesis, biochemistry and molecular docking studies. Bioorg Chem 2015,62,22-29","journal-title":"Bioorg Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"605","DOI":"10.2174\/1570178612666150903213416","volume":"12","author":"Mathew B.","year":"2015","unstructured":"Mathew B.; U\u00e7ar G.; Yabano\u011flu-\u00c7ift\u00e7i S.; Baysal I.; Suresh J.; Mathew G.E.; Vilapurathu J.K.; Nadeena A.M.; Nabeela P.; Lakshmi V.; Haridas A.; Fathima F.; Development of fluorinated thienylchalcones as monoamine oxidase-b inhibitors: Design, synthesis, biological evaluation and molecular docking studies. Lett Org Chem 2015,12,605-613","journal-title":"Lett Org Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1002\/cbdv.201500367","volume":"13","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Mathew G.E.; U\u00e7ar G.; Baysal I.; Suresh J.; Mathew S.; Haridas A.; Jayaprakash V.; Potent and selective monoamine oxidase-b inhibitory activity: Fluoro- vs trifluoromethyl-4-hydroxylated chalcone derivatives. Chem Biodivers 2016,13(8),1046-1052","journal-title":"Chem Biodivers"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ijbiomac.2016.05.110","volume":"91","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Haridas A.; U\u00e7ar G.; Baysal I.; Adeniyi A.A.; Soliman M.E.S.; Joy M.; Mathew G.E.; Lakshmanan B.; Jayaprakash V.; Exploration of chlorinated thienyl chalcones: A new class of monoamine oxidase-B inhibitors. Int J Biol Macromol 2016,91,680-695","journal-title":"Int J Biol Macromol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1002\/cmdc.201600122","volume":"11","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; Haridas A.; U\u00e7ar G.; Baysal I.; Joy M.; Mathew G.E.; Lakshmanan B.; Jayaprakash V.; Synthesis, biochemistry, and computational studies of brominated thienyl chalcones: A new class of reversible MAO-B inhibitors. ChemMedChem 2016,11(11),1161-1171","journal-title":"ChemMedChem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cmdc.201600497","volume":"11","author":"Mathew B.","year":"2016","unstructured":"Mathew B.; U\u00e7ar G.; Mathew G.E.; Mathew S.; Kalatharakkal Purapurath P.; Moolayil F.; Mohan S.; Varghese Gupta S.; Monoamine oxidase inhibitory activity: Methyl- versus chloro-chalcone derivatives. ChemMedChem 2016,11(24),2649-2655","journal-title":"ChemMedChem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/ardp.201600088","volume":"349","author":"Sasidharan R.","year":"2016","unstructured":"Sasidharan R.; Manju S.L.; U\u00e7ar G.; Baysal I.; Mathew B.; Identification of indole based chalcones: Discovery of potent, selective and reversible class of MAO-B inhibitors. Arch Pharm (Weinheim) 2016,349(8),627-637","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.1002\/slct.201702141","volume":"2","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; U\u00e7ar G.; Raphael C.; Mathew G.E.; Joy M.; Machaba K.E.; Characterization of thienylchalcones as hMAO-B inhibitors: Synthesis, biochemistry and molecular dynamics studies. ChemistrySelect 2017,2,11113-11119","journal-title":"ChemistrySelect"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.201800309","volume":"352","author":"Mathew B.","year":"2019","unstructured":"Mathew B.; Baek S.C.; Parambi D.G.T.; Lee J.P.; Mathew G.E.; Jayanthi S.; Vinod D.; Raphael C.; Devikrishna V.; Kondarath S.S.; Uddin M.S.; Kim H.; Potent and highly selective dual-targeting monoamine oxi-dase-B inhibitors: Fluorinated chalcones of morpholine ver-sus imidazole. Arch Pharm (Weinheim) 2019,352(4)","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/14756366.2019.1593158","volume":"34","author":"Shalaby R.","year":"2019","unstructured":"Shalaby R.; Petzer J.P.; Petzer A.; Ashraf U.M.; Atari E.; Alasmari F.; Kumarasamy S.; Sari Y.; Khalil A.; SAR and molecular mechanism studies of monoamine oxidase inhibition by selected chalcone analogs. J Enzyme Inhib Med Chem 2019,34(1),863-876","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/cr020033s","volume":"103","author":"Horton D.A.","year":"2003","unstructured":"Horton D.A.; Bourne G.T.; Smythe M.L.; The combinatorial synthesis of bicyclic privileged structures or privileged substructures. Chem Rev 2003,103(3),893-930","journal-title":"Chem Rev"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11030-013-9490-6","volume":"18","author":"Carradori S.","year":"2014","unstructured":"Carradori S.; D\u2019Ascenzio M.; Chimenti P.; Secci D.; Bolasco A.; Selective MAO-B inhibitors: a lesson from natural products. Mol Divers 2014,18(1),219-243","journal-title":"Mol Divers"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1871524914666140826111930","volume":"14","author":"Mathew B.","year":"2014","unstructured":"Mathew B.; Suresh J.; Mathew G.E.; Parasuraman R.; Abdulla N.; Plant secondary metabolites- potent inhibitors of monoamine oxidase isoforms. Cent Nerv Syst Agents Med Chem 2014,14(1),28-33","journal-title":"Cent Nerv Syst Agents Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"522","DOI":"10.2174\/1386207320666170227155517","volume":"20","author":"Mathew B.","year":"2017","unstructured":"Mathew B.; Mathew G.E.; Petzer J.P.; Petzer A.; Structural exploration of synthetic chromones as selective MAO-B inhibitors. A mini review. Comb Chem High Throughput Screen 2017,20(6),522-532","journal-title":"Comb Chem High Throughput Screen"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1021\/jm2004267","volume":"54","author":"Gaspar A.","year":"2011","unstructured":"Gaspar A.; Silva T.; Y\u00e1\u00f1ez M.; Vi\u00f1a D.; Orallo F.; Ortuso F.; Uriarte E.; Alcaro S.; Borges F.; Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. J Med Chem 2011,54(14),5165-5173","journal-title":"J Med Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/cmdc.201000452","volume":"6","author":"Gaspar A.","year":"2011","unstructured":"Gaspar A.; Teixeira F.; Uriarte E.; Milhazes N.; Melo A.; Cordeiro M.N.D.S.; Ortuso F.; Alcaro S.; Borges F.; Towards the discovery of a novel class of monoamine oxidase inhibitors: structure-property-activity and docking studies on chromone amides. ChemMedChem 2011,6(4),628-632","journal-title":"ChemMedChem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.1021\/acs.jmedchem.6b00527","volume":"59","author":"Reis J.","year":"2016","unstructured":"Reis J.; Cagide F.; Chavarria D.; Silva T.; Fernandes C.; Gaspar A.; Uriarte E.; Remi\u00e3o F.; Alcaro S.; Ortuso F.; Borges F.; Discovery of new chemical entities of old targets. Insight on the lead optimization of chromones based monoamine oxidase B inhibitors. J Med Chem 2016,59(12),5879-5893","journal-title":"J Med Chem"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ejmech.2012.01.037","volume":"49","author":"Legoabe L.J.","year":"2012","unstructured":"Legoabe L.J.; Petzer A.; Petzer J.P.; Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives. Eur J Med Chem 2012,49,343-353","journal-title":"Eur J Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bioorg.2012.08.003","volume":"45","author":"Legoabe L.J.","year":"2012","unstructured":"Legoabe L.J.; Petzer A.; Petzer J.P.; Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors. Bioorg Chem 2012,45,1-11","journal-title":"Bioorg Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bioorg.2014.11.008","volume":"58","author":"Nayak B.V.","year":"2015","unstructured":"Nayak B.V.; Ciftci-Yabanoglu S.; Bhakat S.; Timiri A.K.; Sinha B.N.; U\u00e7ar G.; Soliman M.E.S.; Jayaprakash V.; Monoamine oxidase inhibitory activity of 2-aryl-4H-chromen-4-ones. Bioorg Chem 2015,58,72-80","journal-title":"Bioorg Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1080\/14756366.2019.1634703","volume":"34","author":"Mi Z.","year":"2019","unstructured":"Mi Z.; Gan B.; Yu S.; Guo J.; Zhang C.; Jiang X.; Zhou T.; Su J.; Bai R.; Xie Y.; Dual-target anti-Alzheimer\u2019s disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity. J Enzyme Inhib Med Chem 2019,34(1),1489-1497","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"4846","DOI":"10.1016\/j.ejmech.2011.07.017","volume":"46","author":"Secci D.","year":"2011","unstructured":"Secci D.; Carradori S.; Bolasco A.; Chimenti P.; Y\u00e1\u00f1ez M.; Ortuso F.; Alcaro S.; Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives. Eur J Med Chem 2011,46(10),4846-4852","journal-title":"Eur J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"7206","DOI":"10.1021\/acs.jmedchem.7b00918","volume":"60","author":"Fonseca A.","year":"2017","unstructured":"Fonseca A.; Reis J.; Silva T.; Matos M.J.; Bagetta D.; Ortuso F.; Alcaro S.; Uriarte E.; Borges F.; Coumarin versus chromone monoamine oxidase B inhibitors: Quo vadis? J Med Chem 2017,60(16),7206-7212","journal-title":"J Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ejmech.2014.04.060","volume":"80","author":"Pan Z-X.","year":"2014","unstructured":"Pan Z-X.; He X.; Chen Y-Y.; Tang W-J.; Shi J-B.; Tang Y-L.; Song B-A.; Li J.; Liu X-H.; New 2H-chromene-3-carboxamide derivatives: design, synthesis and use as inhibitors of hMAO. Eur J Med Chem 2014,80,278-284","journal-title":"Eur J Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3732","DOI":"10.1016\/j.bmc.2014.05.002","volume":"22","author":"He X.","year":"2014","unstructured":"He X.; Chen Y-Y.; Shi J-B.; Tang W-J.; Pan Z-X.; Dong Z-Q.; Song B-A.; Li J.; Liu X-H.; New coumarin derivatives: design, synthesis and use as inhibitors of hMAO. Bioorg Med Chem 2014,22(14),3732-3738","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1002\/cmdc.201300533","volume":"9","author":"Matos M.J.","year":"2014","unstructured":"Matos M.J.; Vilar S.; Garc\u00eda-Morales V.; Tatonetti N.P.; Uriarte E.; Santana L.; Vi\u00f1a D.; Insight into the functional and structural properties of 3-arylcoumarin as an interesting scaffold in monoamine oxidase B inhibition. ChemMedChem 2014,9(7),1488-1500","journal-title":"ChemMedChem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.ejmech.2016.09.041","volume":"125","author":"Chementi J.","year":"2017","unstructured":"Chementi J.; Foka G.B.; Repsold B.P.; Oliver D.W.; Kapp E.; Malan S.F.; Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2017,125,853-864","journal-title":"Eur J Med Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1080\/14756366.2019.1571272","volume":"34","author":"Secci D.","year":"2019","unstructured":"Secci D.; Carradori S.; Petzer A.; Guglielmi P.; D\u2019Ascenzio M.; Chimenti P.; Bagetta D.; Alcaro S.; Zengin G.; Petzer J.P.; Ortuso F.; 4-(3-Nitrophenyl) thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis. J Enzyme Inhib Med Chem 2019,34(1),597-612","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.ejmech.2017.10.050","volume":"143","author":"Carradori S.","year":"2018","unstructured":"Carradori S.; Ortuso F.; Petzer A.; Bagetta D.; De Monte C.; Secci D.; De Vita D.; Guglielmi P.; Zengin G.; Aktumsek A.; Alcaro S.; Petzer J.P.; Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents. Eur J Med Chem 2018,143,1543-1552","journal-title":"Eur J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1016\/j.bmc.2010.05.070","volume":"18","author":"Chimenti F.","year":"2010","unstructured":"Chimenti F.; Secci D.; Bolasco A.; Chimenti P.; Granese A.; Carradori S.; Maccioni E.; Cardia M.C.; Y\u00e1\u00f1ez M.; Orallo F.; Alcaro S.; Ortuso F.; Cirilli R.; Ferretti R.; Distinto S.; Kirchmair J.; Langer T.; Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors. Bioorg Med Chem 2010,18(14),5063-5070","journal-title":"Bioorg Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.1021\/jm100120s","volume":"53","author":"Chimenti F.","year":"2010","unstructured":"Chimenti F.; Secci D.; Bolasco A.; Chimenti P.; Granese A.; Carradori S.; Y\u00e1\u00f1ez M.; Orallo F.; Sanna M.L.; Gallinella B.; Cirilli R.; Synthesis, stereochemical separation, and biological evaluation of selective inhibitors of human MAO-B: 1-(4-arylthiazol-2-yl)-2-(3-methyl-cyclohexylidene)hydrazines. J Med Chem 2010,53(17),6516-6520","journal-title":"J Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1016\/j.bmc.2014.03.042","volume":"22","author":"D\u2019Ascenzio M.","year":"2014","unstructured":"D\u2019Ascenzio M.; Carradori S.; Secci D.; Mannina L.; Sobolev A.P.; De Monte C.; Cirilli R.; Y\u00e1\u00f1ez M.; Alcaro S.; Ortuso F.; Identification of the stereochemical requirements in the 4-aryl-2-cycloalkylidenhydrazinyl-thiazole scaffold for the design of selective human monoamine oxidase B inhibitors. Bioorg Med Chem 2014,22(10),2887-2895","journal-title":"Bioorg Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"908","DOI":"10.3109\/14756366.2014.987138","volume":"30","author":"D\u2019Ascenzio M.","year":"2015","unstructured":"D\u2019Ascenzio M.; Chimenti P.; Gidaro M.C.; De Monte C.; De Vita D.; Granese A.; Scipione L.; Di Santo R.; Costa G.; Alcaro S.; Y\u00e1\u00f1ez M.; Carradori S.; (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies. J Enzyme Inhib Med Chem 2015,30(6),908-919","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ejmech.2012.10.032","volume":"58","author":"Secci D.","year":"2012","unstructured":"Secci D.; Bolasco A.; Carradori S.; D\u2019Ascenzio M.; Nescatelli R.; Y\u00e1\u00f1ez M.; Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines. Eur J Med Chem 2012,58,405-417","journal-title":"Eur J Med Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1080\/14756366.2017.1389920","volume":"33","author":"Tripathi R.K.P.","year":"2018","unstructured":"Tripathi R.K.P.; M. Sasi ; V.; Gupta, S.K.; Krishnamurthy, S.; Ayyannan, S.R. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site. J Enzyme Inhib Med Chem 2018,33(1),37-57","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.bioorg.2018.12.019","volume":"85","author":"Sa\u011fl\u0131k B.N.","year":"2019","unstructured":"Sa\u011fl\u0131k B.N.; Kaya \u00c7avu\u015fo\u011flu B.; Osmaniye D.; Levent S.; Acar \u00c7evik U.; Ilg\u0131n S.; \u00d6zkay Y.; Kaplanc\u0131kl\u0131 Z.A.; \u00d6zt\u00fcrk Y.; In vitro and in silico evaluation of new thiazole compounds as monoamine oxidase inhibitors. Bioorg Chem 2019,85,97-108","journal-title":"Bioorg Chem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/157489109789318569","volume":"4","author":"Kumar S.","year":"2009","unstructured":"Kumar S.; Bawa S.; Drabu S.; Kumar R.; Gupta H.; Biological activities of pyrazoline derivatives--a recent development. Recent Pat Antiinfect Drug Discov 2009,4(3),154-163","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"4490","DOI":"10.1016\/j.bmcl.2014.07.085","volume":"24","author":"Neudorfer C.","year":"2014","unstructured":"Neudorfer C.; Shanab K.; Jurik A.; Schreiber V.; Neudorfer C.; Vraka C.; Schirmer E.; Holzer W.; Ecker G.; Mitterhauser M.; Wadsak W.; Spreitzer H.; Development of potential selective and reversible pyrazoline based MAO-B inhibitors as MAO-B PET tracer precursors and reference substances for the early detection of Alzheimer\u2019s disease. Bioorg Med Chem Lett 2014,24(18),4490-4495","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1021\/acsmedchemlett.5b00326","volume":"7","author":"Badavath V.N.","year":"2015","unstructured":"Badavath V.N.; Baysal \u0130.; U\u00e7ar G.; Sinha B.N.; Jayaprakash V.; Monoamine oxidase inhibitory activity of novel pyrazoline analogues: Curcumin based design and synthesis. ACS Med Chem Lett 2015,7(1),56-61","journal-title":"ACS Med Chem Lett"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bmcl.2009.11.015","volume":"20","author":"Sahoo A.","year":"2010","unstructured":"Sahoo A.; Yabanoglu S.; Sinha B.N.; U\u00e7ar G.; Basu A.; Jayaprakash V.; Towards development of selective and reversible pyrazoline based MAO-inhibitors: Synthesis, biological evaluation and docking studies. Bioorg Med Chem Lett 2010,20(1),132-136","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"126","DOI":"10.17179\/excli2017-871","volume":"17","author":"Tripathi A.C.","year":"2018","unstructured":"Tripathi A.C.; Upadhyay S.; Paliwal S.; Saraf S.K.; N1-benzenesulfonyl-2-pyrazoline hybrids in neurological disorders: Syntheses, biological screening and computational studies. EXCLI J 2018,17,126-148","journal-title":"EXCLI J"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.2174\/156802612805220057","volume":"12","author":"Secci D.","year":"2012","unstructured":"Secci D.; Carradori S.; Bolasco A.; Bizzarri B.; D\u2019Ascenzio M.; Maccioni E.; Discovery and optimization of pyrazoline derivatives as promising monoamine oxidase inhibitors. Curr Top Med Chem 2012,12(20),2240-2257","journal-title":"Curr Top Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ejmech.2009.11.003","volume":"45","author":"Chimenti F.","year":"2010","unstructured":"Chimenti F.; Carradori S.; Secci D.; Bolasco A.; Bizzarri B.; Chimenti P.; Granese A.; Y\u00e1\u00f1ez M.; Orallo F.; Synthesis and inhibitory activity against human monoamine oxidase of N1-thiocarbamoyl-3,5-di(hetero)aryl-4,5-dihydro-(1H)-pyrazole derivatives. Eur J Med Chem 2010,45(2),800-804","journal-title":"Eur J Med Chem"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00702-013-0980-6","volume":"120","author":"Salgin-G\u00f6k\u015fen U.","year":"2013","unstructured":"Salgin-G\u00f6k\u015fen U.; Yabano\u011flu-\u00c7ift\u00e7i S.; Ercan A.; Yelek\u00e7i K.; U\u00e7ar G.; G\u00f6khan-Kelek\u00e7i N.; Evaluation of selective human MAO inhibitory activities of some novel pyrazoline derivatives. J Neural Transm (Vienna) 2013,120(6),863-873","journal-title":"J Neural Transm (Vienna)"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.ejmech.2013.09.010","volume":"69","author":"Vishnu Nayak B.","year":"2013","unstructured":"Vishnu Nayak B.; Ciftci-Yabanoglu S.; Jadav S.S.; Jagrat M.; Sinha B.N.; U\u00e7ar G.; Jayaprakash V.; Monoamine oxidase inhibitory activity of 3,5-biaryl-4,5-dihydro-1H-pyrazole-1-carboxylate derivatives. Eur J Med Chem 2013,69,762-767","journal-title":"Eur J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1016\/j.bmcl.2014.06.015","volume":"24","author":"Evranos-Aks\u00f6z B.","year":"2014","unstructured":"Evranos-Aks\u00f6z B.; Yabano\u011flu-\u00c7ift\u00e7i S.; U\u00e7ar G.; Yelek\u00e7i K.; Ertan R.; Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies. Bioorg Med Chem Lett 2014,24(15),3278-3284","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"484","DOI":"10.3390\/molecules24030484","volume":"24","author":"Guglielmi P.","year":"2019","unstructured":"Guglielmi P.; Carradori S.; Poli G.; Secci D.; Cirilli R.; Rotondi G.; Chimenti P.; Petzer A.; Petzer J.P.; Design, synthesis, docking studies and monoamine oxidase inhibition of a small library of 1-acetyl- and 1-thiocarbamoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazoles. Molecules 2019,24(3),484","journal-title":"Molecules"},{"key":"ref=91","year":"2019","unstructured":"Small change for big improvement: halogen bonds and drug discovery Heidelberg Institute for Theoretical Studies2019","journal-title":"Small change for big improvement: halogen bonds and drug discovery"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/178487","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/178487\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/178487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T10:16:48Z","timestamp":1665569808000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178487\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,12,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666200121165931","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-07","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}